BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cross TJ, Calvaruso V, Maimone S, Carey I, Chang TP, Pleguezuelo M, Manousou P, Quaglia A, Grillo F, Dhillon AP. Prospective comparison of Fibroscan, King’s score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J Viral Hepat. 2010;17:546-554. [PMID: 19874477 DOI: 10.1111/j.1365-2893.2009.01210.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Gudowska M, Wrona A, Gruszewska E, Panasiuk A, Cylwik B, Swiderska M, Filisiak R, Szmitkowski M, Chrostek L. Simple non-invasive markers for early diagnosis and determination of the severity of liver diseases. Clin Exp Hepatol 2016;2:149-54. [PMID: 28856280 DOI: 10.5114/ceh.2016.63872] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Cross TJS, Calvaruso V, Foxton MR, Manousou P, Quaglia A, Grillo F, Dhillon AP, Nolan J, Chang TP, O’grady J, Heneghan MA, O’beirne JP, Burroughs AK, Harrison PM. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation: Noninvasive test for hepatitis C-related fibrosis post-LT. Journal of Viral Hepatitis 2010;17:640-9. [DOI: 10.1111/j.1365-2893.2009.01222.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
3 Deng H, Qi X, Guo X. Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015;94:e1795. [PMID: 26496312 DOI: 10.1097/md.0000000000001795] [Cited by in Crossref: 55] [Cited by in F6Publishing: 28] [Article Influence: 9.2] [Reference Citation Analysis]
4 Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, Boisson RC, Bosson JL, Guyader D, Renversez JC, Bronowicki JP, Gelineau MC, Tran A, Trocme C, De Ledinghen V, Lasnier E, Poujol-Robert A, Ziegler F, Bourliere M, Voitot H, Larrey D, Rosenthal-Allieri MA, Fouchard Hubert I, Bailly F, Vaubourdolle M;  ANRS HCEP 23 Fibrostar Group. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol. 2012;56:55-62. [PMID: 21781944 DOI: 10.1016/j.jhep.2011.05.024] [Cited by in Crossref: 142] [Cited by in F6Publishing: 126] [Article Influence: 12.9] [Reference Citation Analysis]
5 Chrostek L, Przekop D, Gruszewska E, Gudowska-Sawczuk M, Cylwik B. Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics. Biomed Res Int 2019;2019:3646975. [PMID: 31192254 DOI: 10.1155/2019/3646975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 European Association for Study of Liver. Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237-264. [PMID: 25911335 DOI: 10.1016/j.jhep.2015.04.006] [Cited by in Crossref: 918] [Cited by in F6Publishing: 787] [Article Influence: 131.1] [Reference Citation Analysis]
7 Kemp W, Levy M, Weltman M, Lubel J. Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis. J Gastroenterol Hepatol. 2015;30:453-462. [PMID: 25532416 DOI: 10.1111/jgh.12865] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
8 Omran D, Zayed RA, Nabeel MM, Mobarak L, Zakaria Z, Farid A, Hassany M, Saif S, Mostafa M, Saad OK, Yosry A. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients. Viral Immunol 2018;31:315-20. [PMID: 29630460 DOI: 10.1089/vim.2017.0134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Ding H, Wu T, Ma K, Wang X, Wu Z, Guo W, Qi J, Ning Q. Noninvasive measurement of liver fibrosis by transient elastography and influencing factors in patients with chronic hepatitis B-A single center retrospective study of 466 patients. J Huazhong Univ Sci Technolog Med Sci 2012;32:69-74. [PMID: 22282248 DOI: 10.1007/s11596-012-0012-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
10 Gudowska M, Gruszewska E, Panasiuk A, Cylwik B, Swiderska M, Flisiak R, Szmitkowski M, Chrostek L. High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases. Prz Gastroenterol 2017;12:203-7. [PMID: 29123582 DOI: 10.5114/pg.2017.70474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Davidson B, Rodríguez-Perálvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-409, v-vi. [PMID: 25633908 DOI: 10.3310/hta19090] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 12.0] [Reference Citation Analysis]
12 Gudowska M, Gruszewska E, Panasiuk A, Cylwik B, Świderska M, Flisiak R, Szmitkowski M, Chrostek L. Selected Noninvasive Markers in Diagnosing Liver Diseases. Lab Med 2016;47:67-72. [PMID: 26715612 DOI: 10.1093/labmed/lmv015] [Reference Citation Analysis]
13 Suk KT, Kim DJ, Kim CH, Park SH, Cheong JY, Cho SW, Choi JY, Han KH, Sung HT, Hong SH. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis. Clin Biochem. 2012;45:1075-1080. [PMID: 22579966 DOI: 10.1016/j.clinbiochem.2012.04.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
14 Cross TJS, Rashid MM, Berry PA, Harrison PM. The importance of steatosis in chronic hepatitis C infection and its management: A review. Hepatology Research 2010;40:237-47. [DOI: 10.1111/j.1872-034x.2010.00626.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
15 Shiha G, Seif S, Maher M, Etreby S, Samir W, Zalata K. Comparison between transient elastography (Fibroscan) and liver biopsy for the diagnosis of hepatic fibrosis in chronic hepatitis C genotype 4: . Egyptian Liver Journal 2014;4:106-11. [DOI: 10.1097/01.elx.0000454686.81811.1a] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Androutsakos T, Schina M, Pouliakis A, Kontos A, Sipsas N, Hatzis G. Causative factors of liver fibrosis in HIV-infected patients. A single center study. BMC Gastroenterol 2020;20:91. [PMID: 32252653 DOI: 10.1186/s12876-020-01230-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen Yi Mei SLG, Thompson AJ, Christensen B, Cunningham G, McDonald L, Bell S, Iser D, Nguyen T, Desmond PV. Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection. PLoS One 2017;12:e0185609. [PMID: 29065124 DOI: 10.1371/journal.pone.0185609] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
18 Steadman R, Myers RP, Leggett L, Lorenzetti D, Noseworthy T, Rose S, Sutherland L, Clement F. A health technology assessment of transient elastography in adult liver disease. Can J Gastroenterol 2013;27:149-58. [PMID: 23516679 DOI: 10.1155/2013/684982] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
19 Fallatah HI. Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014;2014:1-15. [DOI: 10.1155/2014/357287] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
20 Nam TH, Park BJ, Sung DJ, Kim MJ, Han NY, Sim KC, Lee JH, Cho SB. Non-invasive assessment of liver fibrosis using acoustic structure quantification: comparison with transient elastography in chronic viral hepatitis. Abdom Radiol (NY) 2016;41:239-47. [PMID: 26867905 DOI: 10.1007/s00261-015-0597-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
21 Sporea I, Şirli R, Popescu A, Bota S, Badea R, Lupşor M, Focşa M, Dănilă M. Is it better to use two elastographic methods for liver fibrosis assessment? World J Gastroenterol 2011; 17(33): 3824-3829 [PMID: 21987625 DOI: 10.3748/wjg.v17.i33.3824] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
22 Helmke S, Colmenero J, Everson GT. Noninvasive assessment of liver function. Curr Opin Gastroenterol. 2015;31:199-208. [PMID: 25714706 DOI: 10.1097/mog.0000000000000167] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
23 Nieto J, Khaleel H, Challita Y, Jimenez M, Baron TH, Walters L, Hathaway K, Patel K, Lankarani A, Herman M, Holloman D, Saab S. EUS-guided fine-needle core liver biopsy sampling using a novel 19-gauge needle with modified 1-pass, 1 actuation wet suction technique. Gastrointest Endosc. 2018;87:469-475. [PMID: 28551024 DOI: 10.1016/j.gie.2017.05.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
24 Selph SS, Ginsburg AD, Chou R. Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis. Syst Rev 2014;3:107. [PMID: 25239493 DOI: 10.1186/2046-4053-3-107] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
25 Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 117] [Cited by in F6Publishing: 97] [Article Influence: 14.6] [Reference Citation Analysis]
26 Ding R, Zhou X, Huang D, Wang Y, Li X, Yan L, Lu W, Yang Z, Zhang Z. Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease. BMC Gastroenterol 2021;21:190. [PMID: 33906623 DOI: 10.1186/s12876-021-01774-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Nieto J, Dawod E, Deshmukh A, Penn E, Adler D, Saab S. EUS-guided fine-needle core liver biopsy with a modified one-pass, one-actuation wet suction technique comparing two types of EUS core needles. Endosc Int Open 2020;8:E938-43. [PMID: 32617398 DOI: 10.1055/a-1165-1767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Fiel MI. Pathology of chronic hepatitis B and chronic hepatitis C. Clin Liver Dis. 2010;14:555-575. [PMID: 21055682 DOI: 10.1016/j.cld.2010.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
29 Sebastiani G, Alberti A. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? J Viral Hepat. 2012;19 Suppl 1:18-32. [PMID: 22233410 DOI: 10.1111/j.1365-2893.2011.01518.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
30 Jerkeman A, Westin J, Lagging M, Norkrans G, Lidman C, Frimand J, Simonsberg C, Kakko J, Widell A, Björkman P. Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy—Factors associated with advanced fibrosis. Scandinavian Journal of Infectious Diseases 2014;46:340-7. [DOI: 10.3109/00365548.2013.879994] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 J.s. Cross T, Jothimani D, Heneghan MA, Harrison PM. Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence: Non-invasive assessment of HCV post OLT. Clinical Transplantation 2011;25:345-51. [DOI: 10.1111/j.1399-0012.2011.01396.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
32 Androutsakos T, Schina M, Pouliakis A, Kontos A, Sipsas N, Hatzis G. Liver Fibrosis Assessment in a Cohort of Greek HIV Mono-Infected Patients by Non-Invasive Biomarkers. Curr HIV Res 2019;17:173-82. [PMID: 31549590 DOI: 10.2174/1570162X17666190809153245] [Reference Citation Analysis]
33 Pinato DJ, Karamanakos G, Ishizuka M, Smirne C, Pirisi M, Kubota K, Sharma R. The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application. Liver Int 2015;35:2458-65. [PMID: 25845291 DOI: 10.1111/liv.12841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Geng XX, Huang RG, Lin JM, Jiang N, Yang XX. Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis. Saudi J Gastroenterol. 2016;22:294-303. [PMID: 27488324 DOI: 10.4103/1319-3767.187603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
35 Ho SY, Liu PH, Hsu CY, Hsia CY, Su CW, He YJ, Lee YH, Huang YH, Hou MC, Huo TI. Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma. Sci Rep 2018;8:15074. [PMID: 30305679 DOI: 10.1038/s41598-018-33536-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
36 Arslan FD, Karakoyun I, Tatar B, Pala EE, Yıldırım M, Ulasoglu C, Duman C, Akar H, Kose S, Isbilen Basok B. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.63310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]